MEBO Private Facebook Group
to join : contact
maria.delatorre@meboresearch.org

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact map@meboresearch.org

MEBO TMAU urine test

MEBO Research
TMAU Urine Test
United States only
PROGRAM IS PERMANENTLY SUSPENDED AS OF 2 MAY 2017

Click here for
REQUISITION FORM
Incomplete applications
will NOT be processed

SEE UPDATES HERE

1
test
$150 plus
shipping costs
2
tests
$250 plus
shipping costs

TWO PAYMENT PLAN OPTION
Send email to maria.delatorre@meboresearch.org to arrange, AFTER filling out Requisition Form, please.

Test analysis performed in batches of 20 or more

DATE: 2 MAY 2017
Currently on : PROGRAM IS TEMPORARILY SUSPENDED

Samples analyzed since June 2012 :
352
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect
BannerFans.com
RESEARCH DETAILS

DONATIONS THRU 31-NOV-2016:
£ 943.03/GBP
$ 568.00/USD

TOTAL at today's ROE
£0.80/GBP = $1.00/USD

£1,398.07 = $1,745.14

MEBO UK PAYPAL FOR TRINZYME

********
MEBO US PAYPAL FOR TRINZYME

Your currency will be automatically converted to USD or GBP by PayPal.

Option: pay with your credit card instead of PayPal account by clicking on either Donate button above.

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

Thursday, June 8, 2017

P&G TMA inhibitor supplement : 1st sign of patent

TRIMETHYLAMINE INHIBITOR THERAPY

The community has been aware since around August 2015 that Procter & Gamble are working on a supplement which will be a trimethylamine inhibitor in the gut.

For the first time, we can see the patent publicly (published on June 1 2017).
Here is the patent via the freepatentsonline website :
PDF version
Via the site (without images) 
P&G Press Release on product (Aug 2015)

The patent is titled :
COMPOUNDS AND METHODS FOR INHIBITING PRODUCTION OF TRIMETHYLAMINE


It looks like it was filed on Dec 1 2016.

The 'skinny' on this is :
It will be over-the-counter (no prescription needed)
It is being created due to a 2011 paper by Dr Hazen et al at Cleveland Clinic which implicated TMA-oxide as a causal factor in heart disease development.
Dr Hazen et al are working on the supplement under licence to Procter & Gamble.

For now we are digesting the information.
More posts will follow on the subject.
Comments and interpretations are welcome.

Probably the product still has a long way to be on sale.    

The invention provides a method of inhibiting the conversion of choline or carnitine to trimethylamine (TMA) and lowering TMAO in an individual comprising administering to the individual a composition comprising a compound set forth in FORMULA (I)

The invention also provides for a method of inhibiting the production of TMA by bacteria comprising administering to the individual a composition comprising a compound set forth in FORMULA (I) wherein the compound is administered in an amount effective to inhibit formation of trimethylamine (TMA) from choline or carnitine in the individual.


get New Posts by EMAIL : Enter your email address :



A EURORDIS and NORD Member Organization

2 comments:

Anonymous said...

This is such a good news for so many people including me ... thanks for sharing and keeping the hope alive ..

Jun 9, 2017, 8:00:00 AM
Anonymous said...

So happy to hear this how long do u think it will be to go on sale

Jun 29, 2017, 5:37:00 PM
Post a Comment